Companies /Healthcare

Biomarin Pharmaceutical Inc

NASDAQ: BMRN Biotechnology
$64.67
▼ $0.63 (−0.96%) today
Markets closed · 2:38pm ET

BMRN Coverage

Page 11
9:06am ET
Health and Healthcare

BioMarin Drug Meets Endpoint and Will Seek FDA Approval

via Wikimedia CommonsBioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is surging on news that a drug met its primary endpoint and that it will seek approval in early 2013. The company’s Phase III study of GALNS is…

Jon C. Ogg